Skip to main navigation Skip to search Skip to main content

Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines

  • Margaret A. Tempero
  • , Mokenge P. Malafa
  • , E. Gabriela Chiorean
  • , Brian Czito
  • , Courtney Scaife
  • , Amol K. Narang
  • , Christos Fountzilas
  • , Brian M. Wolpin
  • , Mahmoud Al-Hawary
  • , Horacio Asbun
  • , Stephen W. Behrman
  • , Al B. Benson
  • , Ellen Binder
  • , Dana B. Cardin
  • , Charles Cha
  • , Vincent Chung
  • , Mary Dillhoff
  • , Efrat Dotan
  • , Cristina R. Ferrone
  • , George Fisher
  • Jeffrey Hardacre, William G. Hawkins, Andrew H. Ko, Noelle LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Eileen M. O’Reilly, Jorge Obando, Sushanth Reddy, Sarah Thayer, Robert A. Wolff, Jennifer L. Burns, Griselda Zuccarino-Catania
  • University of California at San Francisco
  • University of South Florida
  • Seattle Cancer Care Alliance
  • Duke University
  • University of Utah
  • Johns Hopkins University
  • Roswell Park Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center
  • University of Michigan, Ann Arbor
  • Mayo Clinic
  • University of Tennessee Health Science Center
  • Northwestern University
  • Washington University St. Louis
  • Vanderbilt University
  • Yale University
  • City of Hope National Medical Center
  • Ohio State University
  • Massachusetts General Hospital Cancer Center
  • Stanford University
  • Case Western Reserve University
  • University of Wisconsin-Madison
  • University of California at San Diego
  • Pancreatic Cancer Action Network
  • Memorial Sloan-Kettering Cancer Center
  • University of Alabama at Birmingham
  • University of Nebraska Medical Center
  • University of Texas MD Anderson Cancer Center
  • National Comprehensive Cancer Network

Research output: Contribution to journalArticlepeer-review

341 Scopus citations

Abstract

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

Original languageEnglish
Pages (from-to)202-210
Number of pages9
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume17
Issue number3
DOIs
StatePublished - Mar 2019

Keywords

  • Adenocarcinoma/diagnosis
  • Disease Management
  • Humans
  • Pancreatic Neoplasms/diagnosis

Fingerprint

Dive into the research topics of 'Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this